on AI/ML Innovations Inc. (CVE:AIML)
AI/ML Innovations Inc. Appoints Dr. Paul Dorian to Lead Medical Advisory Board
AI/ML Innovations Inc. has appointed Dr. Paul Dorian as its Medical Innovation Architect and head of the Medical Advisory Board. Dr. Dorian, a globally recognized cardiologist, brings expertise in cardiac electrophysiology and clinical research. He succeeds Peter Kendall in this role as the company advances its AI-driven cardiac diagnostic technologies.
Dr. Dorian has collaborated with AI/ML Innovations over recent months, influencing product strategy and innovation across the company’s platforms. His appointment aims to enhance the company's clinical leadership as it enters a phase of clinical validation and global deployment.
Paul Duffy, CEO, remarked on Dr. Dorian's unparalleled expertise and leadership, emphasizing its impact on ensuring the clinical relevance, safety, and impact of the company’s technologies as they expand into regulated markets.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all AI/ML Innovations Inc. news